skip to content
Primary navigation


DrugNimotop® (nimodipine)

May 2010

Therapeutic area - CV


Nimotop is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms.

Only the generic product is available.

Authorization criteria

Approved only for use in patients with subarachnoid hemorrhage.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top